Clinical Trial Update: Lamotrigine as Treatment of Myotonia [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 trial evaluating lamotrigine for treating myotonia disorders, including Dystrophia Myotonica Type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophia Myotonica Type 1
• Hyperkalemic Periodic Paralysis
• Myotonia Congenita
• Paramyotonia Congenita
• Potassium-aggravated Myotonia

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: Grete Andersen, MD | Conditions: Dystrophia Myotonica Type 1, Myotonia Congenita | Phase 3 | Status: COMPLETED